2m 2m 2m 2m 2m 2m 2m
GlucoTrack (GCTK)
NASDAQ
$2.50-$0.05 (-2.04%)
Price as of Sep 11, 2026 7:59 PM EDT- $2.0MMarket Cap
- -98.39%1-Year Change
- Medical DevicesIndustry
GlucoTrack (GCTK)
$2.50-$0.05 (-2.04%)
GCTK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.55 | ||
Change | -$0.68 (-21.05%) | ||
Open | $3.06 | ||
High | $3.06 | ||
Low | $2.26 | ||
Previous Close | $3.23 | ||
Volume | 744,247 | ||
30-Day Average Volume | 170,331 | ||
1-Week Change | -14.43% | ||
1-Month Change | -54.26% | ||
1-Year Change | -98.39% | ||
3-Year Change | -99.99% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 798,144 | ||
Total Assets | $1.5M | ||
Market Cap | $2.0M | ||
Enterprise Value | $2.9M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$3.8M | ||
Free Cash Flow | -$3.6M | ||
EBIT | -$3.8M | ||
EBITDA | -$3.8M | ||
Net Working Capital | -$1.6M | ||
EPS | $11.40 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | 0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -1 | ||
Price/Operating Cash Flow | -1 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 15 | ||
Last Split Date | 08/31/2026 | ||
Earnings & Revenue